RxDoctor Payments Data

Kunal Yadav

Transplant Surgery · Toledo, OHNPI 1346592458

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,167 of the $1,355 with a category attached, or 86.2%. 12 manufacturers reported payments, led by Dornier Medtech America, Inc at 30.8% of the total. Reporting peaked in 2023 at $784 and has fallen 80.5% since, to $153 in 2025. That places this record below the midpoint for transplant surgery clinicians in OH, where the typical reported total is $1,754.

$1,355in general payments, 2019–2025

Across 17 payments — averaging $79.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dornier Medtech America, Inc$418
  • Astellas Pharma US Inc$195
  • Mallinckrodt Hospital Products Inc.$153
  • Boston Scientific$123
  • Procept Biorobotics Corporation$118
  • Angiodynamics, Inc.$114
  • plus $234 from 6 others

What the payments were for

  • Food & beverage$1,16786%
  • Education$18714%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,355 in reported general payments places this provider in the 45th percentile of 43 transplant surgery providers in Ohio.

See all transplant surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$200,713
Medicare patients
100
Services billed
852

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valganciclovir Hcl215$31,826
Envarsus XrTacrolimus37$22,469
JanuviaSitagliptin Phosphate28$18,210
Atovaquone26$15,264
Cinacalcet Hcl37$14,459
EliquisApixaban13$12,620
Clotrimazole249$11,928
Mycophenolic AcidMycophenolate Sodium32$11,660
Bumetanide53$1,463
Nifedipine ErNifedipine59$1,440
Famotidine202$1,189
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim278$765
Prednisone177$685
Carvedilol101$578
Nystatin19$558

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$18$18,21028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 43 transplant surgery providers in Ohio.

Other transplant surgery in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →